Alpha blockers (AB), 5-alpha reductase inhibitors (5-ARI) and combination therapy are widely prescribed for lower urinary tract symptoms (LUTS) considered consequent to prostatic enlargement and are the mainstay of first-line therapy. This retrospective interrogation of a large population-based dataset of...
Despite universal adoption and significant technological innovation since its inception around 30 years ago, access to laparoscopic surgery remains lacking in Sub-Saharan Africa (SSA). Whilst some progress has been made in recent years to bridge the gap with the developed...
Unscheduled haematuria admissions ranks among the most common urological emergencies, yet its investigation and management still lack standardisation. The readmission rate for haematuria is substantial, with reports as high as 8%, and the median hospital stay for such cases in...
The concept of ‘evidence-based medicine’ (EBM) was first developed in the early 1990s and was described as “the conscientious, explicit and judicious use of the current best evidence in making decisions about the care of individual patients” by the recently...
Timing is everything.’ Although an expression most frequently linked to comedy, timing also seems just as critical in the business of sexual climax. Indeed, many men worry about ejaculating. Too soon is embarrassing. Too slow is frustrating. And not ejaculating...
Prostate Scotland notes the recommendation from the UK National Screening Committee (NSC) on Friday 28 November 2025 to introduce targeted prostate cancer screening only for men with confirmed BRCA1 or BRCA2 gene variants. While this represents an important first step...
2 March 2022
| Kathryn Ball, Jonathan Charles Goddard
|
URO - Technology
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). This month, I am joined once again by Kassie Ball to discuss the...
1 November 2014
| Karen De Souza, Alexandra Dudek, Simon Chowdhury
|
URO - Urologic Oncology
Testicular cancer (TC) is the most successfully treated solid tumour, achieving a cure rate of 90-95% [1-3]. Testicular cancer is relatively rare with an incidence of 2207 cases in the UK in 2014 [4] and yet is the most common...
In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). I’ve always found the derivation of names fascinating. Anatomy lessons were made so...
Action Bladder Cancer UK (ABC UK) will open applications in November 2024 for its 2026 research funding programmes, supporting projects that improve the care, treatment, or diagnosis of bladder cancer. Grants are offered under two schemes. The Improving Outcomes for...
Action Bladder Cancer UK (ABC UK) is inviting applications for its 2026 research funding programmes, supporting projects that improve the care, treatment or diagnosis of bladder cancer. Grants are offered under two schemes. The Improving Outcomes for Patients Programme (IOPP)...
Action Bladder Cancer UK (ABC UK) is inviting specialist urology and cancer nurses to apply for funding to deliver nurse-led projects that improve bladder cancer care, patient experience and treatment pathways. The ABC UK Nursing Grants Programme offers grants of...